• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CEO

Jim Foster
CRO

Longtime Charles River CEO to retire; COO will take the helm

After more than 30 years as president and CEO, Jim Foster plans to retire from the CRO giant on May 5, with COO Birgit Girshick taking his place.
Darren Incorvaia Jan 8, 2026 12:54pm
New CEO executive boardroom leader
Favicon Fierce Pharma

Amgen obesity marketing head Boulton departs to lead Prolynx

Dec 11, 2025 10:40am
bowel

Olympus-backed Swan EndoSurgical taps Stryker vet for CEO

Dec 3, 2025 9:20am
Novocure TTFields

Novocure replaces CEO after less than a year

Dec 2, 2025 9:35am
Abstract arrangement of geometric shapes including spheres a pyramid and balancing wooden and stone slabs

82% of industry CEOs concerned about FDA's abilities: survey

Nov 21, 2025 4:38pm
Qiagen HQ

Qiagen CEO to step down as company snaps up Parse Biosciences

Nov 4, 2025 2:22pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings